Saturday

3rd Dec 2022

Will coronavirus change EU's pharma supply chain?

  • The French National Pharmaceutical Academy estimates that the EU imports 80 percent of its 'active pharmaceutical ingredients' - mostly from China and India (Photo: Grumpy-Puddin)

The impact of the coronavirus on China and India, two of the world's largest pharmaceutical exporters, has disrupted medicine supply chains worldwide, seeing manufacturing, distribution and trade restrictions, plus short-term scarcities for certain products.

"This crisis has revealed our morbid dependency on China and India as regards pharmaceuticals," the European Commission vice-president Vera Jourova said on Sunday (April 19) in a debate on Czech state television.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

"This is something that makes us vulnerable and we have to make a radical change there," she added, stressing that "this is a big lesson we have learnt".

While many countries depend on China for supplies of masks, tests kits and other antivirus gear, India remains the world's top export of so-called 'generics', such as paracetamol and the anti-malarial drug hydroxychloroquine which is being tested as a possible treatment for Covid-19.

The global race for hydroxychloroquine forced India to put restrictions on its pharmaceutical exports in March, but the country rapidly changed its position amid pressure from the US.

According to Jourová, the commission will reassess the EU's pharmaceutical supply chains and try to diversify them to produce within the bloc as many supplies as possible.

This action plan will then be put to MEPs and member states.

France and some other EU countries have already urged more manufacturing "sovereignty" from foreign supplies in strategic value chains.

"There will be a 'before' and an 'after' the coronavirus in global economics," warned French finance minister Bruno Le Maire last month.

'Isolationism' risks

The European Commission recently published guidelines for member states on the optimisation of supply of medicines and stockpiling, linked to the Covid-19 pandemic, and urged member states to lift exports bans.

However, some export restrictions of medical supplies remain across the bloc, in member states such as Hungary or Belgium.

Some experts have warned of the negative consequences of these measures, stressing the pharmaceutical supply chain is intended to work across borders.

"The consequences of export bans are directly detrimental to the availability of medicines for patients across the EU and globally, as well as risking retaliatory measures from other regions that could impact timely availability of medicines for European patients," the European Federation of Pharmaceutical Industries and Associations (EFPIA) said in a statement.

"No one country can meet all its needs on its own, and through restrictions, countries risk isolating themselves and their citizens from the global supply network," they added.

Additionally, the EFPIA called on the commission to ensure that member states should not take unilateral decisions that could negatively impact on the supply of essential new vaccines, diagnostics and treatments.

'Profiteering'

Meanwhile, a group of 20 NGOs and academics in the UK have voiced concerns about the risk of pharmaceutical companies profiteering off the pandemic or creating barriers for researchers attempting to build up new knowledge.

"There is a real danger that without safeguards, pharmaceutical companies may gain exclusive rights to a new vaccine, which in turn could lead to price gouging and unaffordable prices for millions of people," write the authors in an open letter.

The upcoming EU pharmaceutical strategy, which will be unveiled by the commission at the end of 2020, is expected to reflect the experiences linked to the coronavirus pandemic and propose specific actions to secure supplies and ensure innovation for patients.

As a part of the new industrial strategy announced last March, the new pharmaceutical roadmap also aims to address pharmaceutical pricing, as well making the sector more environment-friendly.

Column

Saving Europe from corona's nasty geopolitics

Four months into the corona crisis and one month into the social and economic shutdown, it seems the big geopolitical loser of the pandemic is likely going to be Europe.

Opinion

The plight of Europe's disabled under coronavirus

'As a single mother, I am now caring for my severely disabled son alone, 24/7, without any assistance, without rest, with more demand for shopping, cooking, feeding and intensive care.'

Von der Leyen: new budget will be EU's corona response

The Commission argues that by using the next EU budget to leverage money guaranteed by member states, it could both circumvent the tricky issue of 'coronabonds' and allow larger overall investment.

MEPs boycott awards over controversial sponsorship

Two MEPs have withdrawn their nominations from the MEPs Awards over the Swiss pharmaceutical company Novartis's participation as a sponsor — currently involved in an alleged bribery scandal in Greece.

Opinion

How EU banks underwrote the Qatar World Cup

European banks and investors have invested heavily in Qatari sovereign bonds, and construction and hospitality companies — with scant attention to well-documented human rights violations.

Stakeholders' Highlights

  1. Nordic Council of MinistersCOP27: Food systems transformation for climate action
  2. Nordic Council of MinistersThe Nordic Region and the African Union urge the COP27 to talk about gender equality
  3. International Sustainable Finance CentreJoin CEE Sustainable Finance Summit, 15 – 19 May 2023, high-level event for finance & business
  4. Friedrich Naumann Foundation European DialogueGender x Geopolitics: Shaping an Inclusive Foreign Security Policy for Europe
  5. Obama FoundationThe Obama Foundation Opens Applications for its Leaders Program in Europe
  6. EFBWW – EFBH – FETBBA lot more needs to be done to better protect construction workers from asbestos

Latest News

  1. EU must break Orbán's veto on a tax rate for multinationals
  2. Belarus dictator's family loves EU luxuries, flight data shows
  3. How Berlin and Paris sold-out the EU corporate due diligence law
  4. Turkey's EU-funded detention centres ripe with abuse: NGO
  5. In green subsidy race, EU should not imitate US
  6. EU Commission proposes suspending billions to Hungary
  7. EU: Russian assets to be returned in case of peace treaty
  8. Frontex leadership candidates grilled by MEPs

Stakeholders' Highlights

  1. European Committee of the RegionsRe-Watch EURegions Week 2022
  2. UNESDA - Soft Drinks EuropeCall for EU action – SMEs in the beverage industry call for fairer access to recycled material
  3. Nordic Council of MinistersNordic prime ministers: “We will deepen co-operation on defence”
  4. EFBWW – EFBH – FETBBConstruction workers can check wages and working conditions in 36 countries
  5. Nordic Council of MinistersNordic and Canadian ministers join forces to combat harmful content online
  6. European Centre for Press and Media FreedomEuropean Anti-SLAPP Conference 2022

Join EUobserver

Support quality EU news

Join us